Drug search by name
Canakinumab Subcutaneous and Xultophy 100/3.6
Determining the interaction of Canakinumab Subcutaneous and Xultophy 100/3.6 and the possibility of their joint administration.
Check result:
Canakinumab Subcutaneous <> Xultophy 100/3.6
Relevance: 24.10.2022
Reviewer: Shkutko P.M., M.D., in
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Canakinumab Subcutaneous
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Xultophy 100/3.6
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Xultophy
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
The list of popular interactions
- Canakinumab Subcutaneous-Xuriden
- Canakinumab Subcutaneous-Xylocaine
- Canakinumab Subcutaneous-Xylocaine (Cardiac)
- Canakinumab Subcutaneous-Xylocaine (Lidocaine Injection Solution (Anesthetic))
- Canakinumab Subcutaneous-Xylocaine (Lidocaine Oral Liquid and Solution)
- Canakinumab Subcutaneous-Xylocaine Dental
- Xultophy 100/3.6-Canasa
- Xultophy 100/3.6-Canasa Pac rectal
- Xultophy 100/3.6-Canasa rectal
- Xultophy 100/3.6-Cancidas
- Xultophy 100/3.6-Candesartan
- Xultophy 100/3.6-Candesartan and Hydrochlorothiazide
Doktika World
Interaction with food and lifestyle
Disease interaction